Cost-effectiveness of ribociclib for premenopausal or perimenopausal women with HR+/HER2− advanced breast cancer: a Brazilian public health care system perspective
- Resource Type
- article
- Source
- Therapeutic Advances in Medical Oncology, Vol 14 (2022)
- Subject
Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 - Language
- English
- ISSN
- 1758-8359
17588359